Advisory Services Network, LLC - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 193 filers reported holding NEKTAR THERAPEUTICS in Q1 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.

Quarter-by-quarter ownership
Advisory Services Network, LLC ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q1 2023$2
-71.4%
30.0%0.00%
Q4 2022$7
-99.6%
3
-97.1%
0.00%
Q3 2020$2,000
-96.9%
103
-97.2%
0.00%
-100.0%
Q1 2020$65,000
+38.3%
3,652
+70.8%
0.00%
+100.0%
Q4 2019$47,000
+840.0%
2,138
+1325.3%
0.00%
Q3 2019$5,0000.0%1500.0%0.00%
Q2 2019$5,000
-58.3%
150
-57.1%
0.00%
-100.0%
Q1 2019$12,000
+50.0%
350
+40.0%
0.00%0.0%
Q4 2018$8,000
-85.2%
250
-72.0%
0.00%
-75.0%
Q3 2018$54,000
+20.0%
8940.0%0.00%
+33.3%
Q2 2018$45,000
+800.0%
894
+1688.0%
0.00%
Q1 2018$5,000
-16.7%
50
-50.0%
0.00%
-100.0%
Q4 2017$6,000
-14.3%
100
-75.0%
0.00%0.0%
Q3 2016$7,000
+16.7%
4000.0%0.00%0.0%
Q2 2016$6,000
+200.0%
400
+100.0%
0.00%0.0%
Q3 2015$2,0000.0%2000.0%0.00%0.0%
Q2 2015$2,0000.0%2000.0%0.00%0.0%
Q1 2015$2,0002000.00%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q1 2023
NameSharesValueWeighting ↓
Camber Capital Management LP 2,000,000$67,200,0003.35%
First Light Asset Management, LLC 763,403$25,650,0003.33%
BRIDGER MANAGEMENT, LLC 1,238,489$41,613,0003.29%
Rhenman & Partners Asset Management AB 734,445$24,677,0002.89%
BB BIOTECH AG 2,020,676$67,895,0001.71%
Gs Investments, Inc. 54,200$1,821,120,0001.43%
Artal Group S.A. 900,000$30,240,0001.24%
Cormorant Asset Management, LP 500,000$16,800,0001.14%
TOBAM 640,547$21,522,0001.09%
Bellevue Group AG 430,026$14,449,0000.80%
View complete list of NEKTAR THERAPEUTICS shareholders